What Are Adequate Treatment and Follow-up Care for Nonmelanoma Cutaneous Cancer?
- 1 March 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 123 (3) , 331-333
- https://doi.org/10.1001/archderm.1987.01660270069016
Abstract
Despite occasional case reports, metastases from basal cell carcinomas (BCCs) are exceedingly rare; the morbidity and mortality they cause is generally the result of direct extension of the cancer into adjacent structures.1-5 If a BCC is left untreated or inadequately treated, this characteristic indolent growth pattern permits it to erode large areas of tissue before causing death. Thus, in the not-too-distant past, it was not uncommon for a BCC to destroy the whole side of the face, leaving the inside of the mouth visible through what had formerly been the cheek. Such lesions were called "rodent ulcers," because they looked as if a rat had gnawed a hole. Nonetheless, both the public and the medical profession had little awareness of the dangers of such lesions; therefore, they often went unrecognized or untreated for long periods of time and were usually presented for treatment at advanced stages.This publication has 6 references indexed in Scilit:
- Metastatic basal cell carcinomaJournal of the American Academy of Dermatology, 1984
- Metastatic basal cell carcinoma: A clinicopathologic study of seventeen casesCancer, 1980
- AN APPRAISAL OF THE TREATMENT OF BASAL CELL CARCINOMA OF THE SKINPlastic and Reconstructive Surgery, 1973
- Partial regression in primary cutaneous malignant melanomaPathology, 1971
- Surgical Therapy of Basal Cell Carcinoma: Correlation of the Macroscopic and Microscopic Control of Excision with RecurrenceScandinavian Journal of Plastic and Reconstructive Surgery, 1971
- Observations on the Critical Margin for the Complete Excision of Carcinoma of the SkinArchives of Dermatology, 1959